Circadian shares lose their rhythm

Article Abstract:

Issues concerning the poor market performance of Circadian Technologies are discussed. Particular attention is given to statistic information reflecting the company's performance on the biotechnology market since its establishment in 1985.

Management, Biotechnology, Circadian Technologies

---

Sonic's boom comes at a cost

Article Abstract:

Sonic Healthcare now controls 35% of Australian's private pathology business. Issues concerning its recent purchases, economic policy and its ability to extract value from the acquisitions are presented.

Mergers, acquisitions and divestments, Sonic Healthcare Ltd.

---

Biotechnology comes to life

Article Abstract:

Advice on investing in the biotechnology industry is presented. Investors are becoming more interested in investing biotechnology stocks following the decline of dot-com firms.

Biotechnology industry, Biotechnology industries, Investments, Study and teaching, Investors

Similar abstracts:

• Abstracts: The future at the speed of thought. New-economy companies to work for. To hell and back
• Abstracts: Educational services industry. Tobacco industry
• Abstracts: Deutsche puts its mistakes behind it. Big returns from smaller stocks. Soul survivor
• Abstracts: Online training cuts costs for companies. Melbourne IT limps along. Keycorp aims to unlock profits with Telstra link

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.